HEADER TRANSFERASE 09-JUN-20 6XD3 TITLE STRUCTURE OF THE HUMAN CAK IN COMPLEX WITH THZ1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CDK-ACTIVATING KINASE ASSEMBLY FACTOR MAT1; COMPND 3 CHAIN: H; COMPND 4 FRAGMENT: RESIDUES 220-309; COMPND 5 SYNONYM: CDK7/CYCLIN-H ASSEMBLY FACTOR,CYCLIN-G1-INTERACTING PROTEIN, COMPND 6 MENAGE A TROIS,RING FINGER PROTEIN 66,RING FINGER PROTEIN MAT1,P35, COMPND 7 P36; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CYCLIN-H; COMPND 11 CHAIN: I; COMPND 12 SYNONYM: MO15-ASSOCIATED PROTEIN,P34,P37; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: CYCLIN-DEPENDENT KINASE 7; COMPND 16 CHAIN: J; COMPND 17 SYNONYM: 39 KDA PROTEIN KINASE,P39 MO15,CDK-ACTIVATING KINASE 1,CELL COMPND 18 DIVISION PROTEIN KINASE 7,SERINE/THREONINE-PROTEIN KINASE 1,TFIIH COMPND 19 BASAL TRANSCRIPTION FACTOR COMPLEX KINASE SUBUNIT; COMPND 20 EC: 2.7.11.22,2.7.11.23; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MNAT1, CAP35, MAT1, RNF66; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HIGH5; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: CCNH; SOURCE 15 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 16 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 18 MOL_ID: 3; SOURCE 19 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 20 ORGANISM_COMMON: HUMAN; SOURCE 21 ORGANISM_TAXID: 9606; SOURCE 22 GENE: CDK7, CAK, CAK1, CDKN7, MO15, STK1; SOURCE 23 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 24 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 25 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS KINASE, TRANSCRIPTION, CELL CYCLE, COMPLEX, TRANSFERASE EXPDTA ELECTRON MICROSCOPY AUTHOR B.J.GREBER,J.M.PEREZ-BERTOLDI,K.LIM,A.T.IAVARONE,D.B.TOSO,E.NOGALES REVDAT 2 30-SEP-20 6XD3 1 JRNL REVDAT 1 09-SEP-20 6XD3 0 JRNL AUTH B.J.GREBER,J.M.PEREZ-BERTOLDI,K.LIM,A.T.IAVARONE,D.B.TOSO, JRNL AUTH 2 E.NOGALES JRNL TITL THE CRYOELECTRON MICROSCOPY STRUCTURE OF THE HUMAN JRNL TITL 2 CDK-ACTIVATING KINASE. JRNL REF PROC.NATL.ACAD.SCI.USA V. 117 22849 2020 JRNL REFN ESSN 1091-6490 JRNL PMID 32855301 JRNL DOI 10.1073/PNAS.2009627117 REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : SERIALEM, RELION, CTFFIND, UCSF REMARK 3 CHIMERA, COOT, RELION, RELION, RELION, REMARK 3 RELION, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 6XBZ REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : OTHER REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.300 REMARK 3 NUMBER OF PARTICLES : 31198 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 6XD3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JUN-20. REMARK 100 THE DEPOSITION ID IS D_1000249942. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CDK-ACTIVATING KINASE ASSEMBLY REMARK 245 FACTOR MAT1, CYCLIN-H, CYCLIN- REMARK 245 DEPENDENT KINASE 7 REMARK 245 (E.C.2.7.11.22,2.7.11.23) REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.20 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.90 REMARK 245 SAMPLE DETAILS : RECOMBINANTLY EXPRESSED AS A REMARK 245 TRIMERIC COMPLEX IN INSECT CELLS (MAT1 SUBUNIT TRUNCATED) AND REMARK 245 THEN MODIFIED WITH COVALENT INHIBITOR THZ1 REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 5007 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TALOS ARCTICA REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 300.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 69.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : 72886 REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 200 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER H 217 REMARK 465 ASN H 218 REMARK 465 ALA H 219 REMARK 465 PRO H 220 REMARK 465 VAL H 221 REMARK 465 THR H 222 REMARK 465 PHE H 223 REMARK 465 SER H 224 REMARK 465 THR H 225 REMARK 465 GLY H 226 REMARK 465 ILE H 227 REMARK 465 LYS H 228 REMARK 465 MET H 229 REMARK 465 GLY H 230 REMARK 465 GLN H 231 REMARK 465 HIS H 232 REMARK 465 ILE H 233 REMARK 465 SER H 234 REMARK 465 LEU H 235 REMARK 465 ALA H 236 REMARK 465 PRO H 237 REMARK 465 ILE H 238 REMARK 465 HIS H 239 REMARK 465 LYS H 240 REMARK 465 LEU H 241 REMARK 465 GLU H 242 REMARK 465 GLU H 243 REMARK 465 SER H 309 REMARK 465 LYS I 39 REMARK 465 VAL I 40 REMARK 465 LEU I 41 REMARK 465 LEU I 285 REMARK 465 ALA I 286 REMARK 465 LEU I 287 REMARK 465 ASN I 288 REMARK 465 VAL I 289 REMARK 465 ILE I 290 REMARK 465 THR I 291 REMARK 465 LYS I 292 REMARK 465 LYS I 293 REMARK 465 ARG I 294 REMARK 465 LYS I 295 REMARK 465 GLY I 296 REMARK 465 TYR I 297 REMARK 465 GLU I 298 REMARK 465 ASP I 299 REMARK 465 ASP I 300 REMARK 465 ASP I 301 REMARK 465 TYR I 302 REMARK 465 VAL I 303 REMARK 465 SER I 304 REMARK 465 LYS I 305 REMARK 465 LYS I 306 REMARK 465 SER I 307 REMARK 465 LYS I 308 REMARK 465 HIS I 309 REMARK 465 GLU I 310 REMARK 465 GLU I 311 REMARK 465 GLU I 312 REMARK 465 GLU I 313 REMARK 465 TRP I 314 REMARK 465 THR I 315 REMARK 465 ASP I 316 REMARK 465 ASP I 317 REMARK 465 ASP I 318 REMARK 465 LEU I 319 REMARK 465 VAL I 320 REMARK 465 GLU I 321 REMARK 465 SER I 322 REMARK 465 LEU I 323 REMARK 465 SER J -2 REMARK 465 ASN J -1 REMARK 465 ALA J 0 REMARK 465 MET J 1 REMARK 465 ALA J 2 REMARK 465 LEU J 3 REMARK 465 ASP J 4 REMARK 465 VAL J 5 REMARK 465 LYS J 6 REMARK 465 SER J 7 REMARK 465 ARG J 8 REMARK 465 ALA J 9 REMARK 465 GLY J 46 REMARK 465 HIS J 47 REMARK 465 ARG J 48 REMARK 465 SER J 49 REMARK 465 GLU J 50 REMARK 465 PRO J 313 REMARK 465 VAL J 314 REMARK 465 GLU J 315 REMARK 465 THR J 316 REMARK 465 LEU J 317 REMARK 465 LYS J 318 REMARK 465 GLU J 319 REMARK 465 GLN J 320 REMARK 465 SER J 321 REMARK 465 ASN J 322 REMARK 465 PRO J 323 REMARK 465 ALA J 324 REMARK 465 LEU J 325 REMARK 465 ALA J 326 REMARK 465 ILE J 327 REMARK 465 LYS J 328 REMARK 465 ARG J 329 REMARK 465 LYS J 330 REMARK 465 ARG J 331 REMARK 465 THR J 332 REMARK 465 GLU J 333 REMARK 465 ALA J 334 REMARK 465 LEU J 335 REMARK 465 GLU J 336 REMARK 465 GLN J 337 REMARK 465 GLY J 338 REMARK 465 GLY J 339 REMARK 465 LEU J 340 REMARK 465 PRO J 341 REMARK 465 LYS J 342 REMARK 465 LYS J 343 REMARK 465 LEU J 344 REMARK 465 ILE J 345 REMARK 465 PHE J 346 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR I 86 O LEU I 158 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP I 11 51.30 -94.22 REMARK 500 PRO I 45 -2.37 -58.15 REMARK 500 ARG I 130 77.80 -101.84 REMARK 500 ASN I 183 72.79 53.08 REMARK 500 LYS J 52 -0.62 64.01 REMARK 500 ARG J 136 3.46 -68.79 REMARK 500 ARG J 209 17.78 56.26 REMARK 500 GLU J 234 -1.85 66.31 REMARK 500 PHE J 261 57.05 -95.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE AUTHORS STATE THAT THE PROTEIN IS COVALENTLY MODIFIED AT CDK7 REMARK 600 CYSTEINE 312 WITH A LIGAND. THE LIGAND IN THE ENTRY IS THZ1-R, REMARK 600 WHICH IS THE FORM THAT IS PRESENT AFTER ADDUCT FORMATION, DURING REMARK 600 WHICH ONE C=C DOUBLE BOND IN THZ1 GETS REDUCED BY MICHAEL ADDITION. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue V0G J 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-22123 RELATED DB: EMDB REMARK 900 RELATED ID: 6XBZ RELATED DB: PDB REMARK 900 RELATED ID: EMD-22131 RELATED DB: EMDB REMARK 900 STRUCTURE OF THE HUMAN CAK IN COMPLEX WITH THZ1 DBREF 6XD3 H 220 309 UNP P51948 MAT1_HUMAN 220 309 DBREF 6XD3 I 1 323 UNP P51946 CCNH_HUMAN 1 323 DBREF 6XD3 J 1 346 UNP P50613 CDK7_HUMAN 1 346 SEQADV 6XD3 SER H 217 UNP P51948 EXPRESSION TAG SEQADV 6XD3 ASN H 218 UNP P51948 EXPRESSION TAG SEQADV 6XD3 ALA H 219 UNP P51948 EXPRESSION TAG SEQADV 6XD3 SER J -2 UNP P50613 EXPRESSION TAG SEQADV 6XD3 ASN J -1 UNP P50613 EXPRESSION TAG SEQADV 6XD3 ALA J 0 UNP P50613 EXPRESSION TAG SEQRES 1 H 93 SER ASN ALA PRO VAL THR PHE SER THR GLY ILE LYS MET SEQRES 2 H 93 GLY GLN HIS ILE SER LEU ALA PRO ILE HIS LYS LEU GLU SEQRES 3 H 93 GLU ALA LEU TYR GLU TYR GLN PRO LEU GLN ILE GLU THR SEQRES 4 H 93 TYR GLY PRO HIS VAL PRO GLU LEU GLU MET LEU GLY ARG SEQRES 5 H 93 LEU GLY TYR LEU ASN HIS VAL ARG ALA ALA SER PRO GLN SEQRES 6 H 93 ASP LEU ALA GLY GLY TYR THR SER SER LEU ALA CYS HIS SEQRES 7 H 93 ARG ALA LEU GLN ASP ALA PHE SER GLY LEU PHE TRP GLN SEQRES 8 H 93 PRO SER SEQRES 1 I 323 MET TYR HIS ASN SER SER GLN LYS ARG HIS TRP THR PHE SEQRES 2 I 323 SER SER GLU GLU GLN LEU ALA ARG LEU ARG ALA ASP ALA SEQRES 3 I 323 ASN ARG LYS PHE ARG CYS LYS ALA VAL ALA ASN GLY LYS SEQRES 4 I 323 VAL LEU PRO ASN ASP PRO VAL PHE LEU GLU PRO HIS GLU SEQRES 5 I 323 GLU MET THR LEU CYS LYS TYR TYR GLU LYS ARG LEU LEU SEQRES 6 I 323 GLU PHE CYS SER VAL PHE LYS PRO ALA MET PRO ARG SER SEQRES 7 I 323 VAL VAL GLY THR ALA CYS MET TYR PHE LYS ARG PHE TYR SEQRES 8 I 323 LEU ASN ASN SER VAL MET GLU TYR HIS PRO ARG ILE ILE SEQRES 9 I 323 MET LEU THR CYS ALA PHE LEU ALA CYS LYS VAL ASP GLU SEQRES 10 I 323 PHE ASN VAL SER SER PRO GLN PHE VAL GLY ASN LEU ARG SEQRES 11 I 323 GLU SER PRO LEU GLY GLN GLU LYS ALA LEU GLU GLN ILE SEQRES 12 I 323 LEU GLU TYR GLU LEU LEU LEU ILE GLN GLN LEU ASN PHE SEQRES 13 I 323 HIS LEU ILE VAL HIS ASN PRO TYR ARG PRO PHE GLU GLY SEQRES 14 I 323 PHE LEU ILE ASP LEU LYS THR ARG TYR PRO ILE LEU GLU SEQRES 15 I 323 ASN PRO GLU ILE LEU ARG LYS THR ALA ASP ASP PHE LEU SEQRES 16 I 323 ASN ARG ILE ALA LEU THR ASP ALA TYR LEU LEU TYR THR SEQRES 17 I 323 PRO SER GLN ILE ALA LEU THR ALA ILE LEU SER SER ALA SEQRES 18 I 323 SER ARG ALA GLY ILE THR MET GLU SER TYR LEU SER GLU SEQRES 19 I 323 SER LEU MET LEU LYS GLU ASN ARG THR CYS LEU SER GLN SEQRES 20 I 323 LEU LEU ASP ILE MET LYS SER MET ARG ASN LEU VAL LYS SEQRES 21 I 323 LYS TYR GLU PRO PRO ARG SER GLU GLU VAL ALA VAL LEU SEQRES 22 I 323 LYS GLN LYS LEU GLU ARG CYS HIS SER ALA GLU LEU ALA SEQRES 23 I 323 LEU ASN VAL ILE THR LYS LYS ARG LYS GLY TYR GLU ASP SEQRES 24 I 323 ASP ASP TYR VAL SER LYS LYS SER LYS HIS GLU GLU GLU SEQRES 25 I 323 GLU TRP THR ASP ASP ASP LEU VAL GLU SER LEU SEQRES 1 J 349 SER ASN ALA MET ALA LEU ASP VAL LYS SER ARG ALA LYS SEQRES 2 J 349 ARG TYR GLU LYS LEU ASP PHE LEU GLY GLU GLY GLN PHE SEQRES 3 J 349 ALA THR VAL TYR LYS ALA ARG ASP LYS ASN THR ASN GLN SEQRES 4 J 349 ILE VAL ALA ILE LYS LYS ILE LYS LEU GLY HIS ARG SER SEQRES 5 J 349 GLU ALA LYS ASP GLY ILE ASN ARG THR ALA LEU ARG GLU SEQRES 6 J 349 ILE LYS LEU LEU GLN GLU LEU SER HIS PRO ASN ILE ILE SEQRES 7 J 349 GLY LEU LEU ASP ALA PHE GLY HIS LYS SER ASN ILE SER SEQRES 8 J 349 LEU VAL PHE ASP PHE MET GLU THR ASP LEU GLU VAL ILE SEQRES 9 J 349 ILE LYS ASP ASN SER LEU VAL LEU THR PRO SER HIS ILE SEQRES 10 J 349 LYS ALA TYR MET LEU MET THR LEU GLN GLY LEU GLU TYR SEQRES 11 J 349 LEU HIS GLN HIS TRP ILE LEU HIS ARG ASP LEU LYS PRO SEQRES 12 J 349 ASN ASN LEU LEU LEU ASP GLU ASN GLY VAL LEU LYS LEU SEQRES 13 J 349 ALA ASP PHE GLY LEU ALA LYS SER PHE GLY SEP PRO ASN SEQRES 14 J 349 ARG ALA TYR THR HIS GLN VAL VAL THR ARG TRP TYR ARG SEQRES 15 J 349 ALA PRO GLU LEU LEU PHE GLY ALA ARG MET TYR GLY VAL SEQRES 16 J 349 GLY VAL ASP MET TRP ALA VAL GLY CYS ILE LEU ALA GLU SEQRES 17 J 349 LEU LEU LEU ARG VAL PRO PHE LEU PRO GLY ASP SER ASP SEQRES 18 J 349 LEU ASP GLN LEU THR ARG ILE PHE GLU THR LEU GLY THR SEQRES 19 J 349 PRO THR GLU GLU GLN TRP PRO ASP MET CYS SER LEU PRO SEQRES 20 J 349 ASP TYR VAL THR PHE LYS SER PHE PRO GLY ILE PRO LEU SEQRES 21 J 349 HIS HIS ILE PHE SER ALA ALA GLY ASP ASP LEU LEU ASP SEQRES 22 J 349 LEU ILE GLN GLY LEU PHE LEU PHE ASN PRO CYS ALA ARG SEQRES 23 J 349 ILE THR ALA THR GLN ALA LEU LYS MET LYS TYR PHE SER SEQRES 24 J 349 ASN ARG PRO GLY PRO THR PRO GLY CYS GLN LEU PRO ARG SEQRES 25 J 349 PRO ASN CYS PRO VAL GLU THR LEU LYS GLU GLN SER ASN SEQRES 26 J 349 PRO ALA LEU ALA ILE LYS ARG LYS ARG THR GLU ALA LEU SEQRES 27 J 349 GLU GLN GLY GLY LEU PRO LYS LYS LEU ILE PHE MODRES 6XD3 SEP J 164 SER MODIFIED RESIDUE HET SEP J 164 10 HET V0G J 401 41 HETNAM SEP PHOSPHOSERINE HETNAM V0G N-(3-{[5-CHLORO-4-(1H-INDOL-3-YL)PYRIMIDIN-2- HETNAM 2 V0G YL]AMINO}PHENYL)-4-{[4-(DIMETHYLAMINO) HETNAM 3 V0G BUTANOYL]AMINO}BENZAMIDE HETSYN SEP PHOSPHONOSERINE FORMUL 3 SEP C3 H8 N O6 P FORMUL 4 V0G C31 H30 CL N7 O2 HELIX 1 AA1 GLY H 270 VAL H 275 5 6 HELIX 2 AA2 SER H 279 GLY H 285 1 7 HELIX 3 AA3 SER H 289 PHE H 301 1 13 HELIX 4 AA4 MET I 1 ASN I 4 5 4 HELIX 5 AA5 SER I 5 HIS I 10 1 6 HELIX 6 AA6 SER I 15 ASN I 37 1 23 HELIX 7 AA7 GLU I 49 VAL I 70 1 22 HELIX 8 AA8 PRO I 76 ASN I 94 1 19 HELIX 9 AA9 HIS I 100 ASP I 116 1 17 HELIX 10 AB1 SER I 121 ASN I 128 1 8 HELIX 11 AB2 SER I 132 LEU I 154 1 23 HELIX 12 AB3 PRO I 163 TYR I 178 1 16 HELIX 13 AB4 PRO I 184 LEU I 200 1 17 HELIX 14 AB5 THR I 201 LEU I 206 5 6 HELIX 15 AB6 THR I 208 ALA I 224 1 17 HELIX 16 AB7 MET I 228 GLU I 234 1 7 HELIX 17 AB8 ASN I 241 LYS I 261 1 21 HELIX 18 AB9 SER I 267 ALA I 283 1 17 HELIX 19 AC1 ASN J 56 GLN J 67 1 12 HELIX 20 AC2 LEU J 98 ASP J 104 1 7 HELIX 21 AC3 THR J 110 HIS J 131 1 22 HELIX 22 AC4 THR J 175 ARG J 179 5 5 HELIX 23 AC5 ALA J 180 PHE J 185 1 6 HELIX 24 AC6 VAL J 192 ARG J 209 1 18 HELIX 25 AC7 SER J 217 GLY J 230 1 14 HELIX 26 AC8 ASP J 239 LEU J 243 5 5 HELIX 27 AC9 PRO J 256 PHE J 261 1 6 HELIX 28 AD1 GLY J 265 PHE J 276 1 12 HELIX 29 AD2 THR J 285 LEU J 290 1 6 HELIX 30 AD3 MET J 292 ASN J 297 1 6 HELIX 31 AD4 PRO J 303 LEU J 307 5 5 SHEET 1 AA1 5 GLU J 13 GLY J 21 0 SHEET 2 AA1 5 ALA J 24 ARG J 30 -1 O LYS J 28 N ASP J 16 SHEET 3 AA1 5 ILE J 37 ILE J 43 -1 O VAL J 38 N ALA J 29 SHEET 4 AA1 5 ILE J 87 ASP J 92 -1 O PHE J 91 N ALA J 39 SHEET 5 AA1 5 ASP J 79 GLY J 82 -1 N PHE J 81 O SER J 88 SHEET 1 AA2 3 THR J 96 ASP J 97 0 SHEET 2 AA2 3 LEU J 143 LEU J 145 -1 O LEU J 145 N THR J 96 SHEET 3 AA2 3 LEU J 151 LEU J 153 -1 O LYS J 152 N LEU J 144 SHEET 1 AA3 2 ILE J 133 LEU J 134 0 SHEET 2 AA3 2 LYS J 160 SER J 161 -1 O LYS J 160 N LEU J 134 LINK C GLY J 163 N SEP J 164 1555 1555 1.33 LINK C SEP J 164 N PRO J 165 1555 1555 1.34 LINK SG CYS J 312 C19 V0G J 401 1555 1555 1.74 SITE 1 AC1 10 LEU J 18 ALA J 39 PHE J 91 MET J 94 SITE 2 AC1 10 GLU J 95 THR J 96 LEU J 144 ASP J 155 SITE 3 AC1 10 ASN J 311 CYS J 312 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000